Suspected clozapine poisoning in the UK/Eire, 1992–2003
Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and N-desmethylclozapine (norclozapine) were measured in order to assess the relationship...
Gespeichert in:
Veröffentlicht in: | Forensic science international 2005-12, Vol.155 (2), p.91-99 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 99 |
---|---|
container_issue | 2 |
container_start_page | 91 |
container_title | Forensic science international |
container_volume | 155 |
creator | Flanagan, R.J. Spencer, E.P. Morgan, P.E. Barnes, T.R.E. Dunk, L. |
description | Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and
N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome.
Samples were referred from clinicians, pathologists/coroners, or via the
Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports.
There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4)
mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70)
mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7,
n
=
43) and 1.4 (0–6.0,
n
=
39)
mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6,
n
=
38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30,
n
=
21) days].
Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information. |
doi_str_mv | 10.1016/j.forsciint.2004.10.024 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_17190859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A138862010</galeid><els_id>S0379073804007455</els_id><sourcerecordid>A138862010</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</originalsourceid><addsrcrecordid>eNqFkc2KFDEUhYMoTtv6ClogurJ68lNJJctmGH9wwIXOOqRTN22a6qRMqgRdzTvMG_okpujGRmmQLC7cfOfekxyEXhC8IpiIy93KxZSt92FcUYyb0l1h2jxACyJbWgsq2UO0wKxVNW6ZvEBPct5hjDmn4jG6IIJSQRqxQOrzlAewI3SV7eNPM_gA1RB9jsGHbeVDNX6F6vbj5bVP8KYiStFfd_dlJXuKHjnTZ3h2rEt0-_b6y9X7-ubTuw9X65vacsHGmrkNoS3mG0OMa40wikveKFqqxc5ZbhtGpWoZ6awinFhpyKZ4xp0imKuOLdHrw9whxW8T5FHvfbbQ9yZAnLImLVFYclXAl_-AuzilULxpghmTjGFBT9TW9KB9cHFMxs4j9ZowKQXFhV6i-gy1hQDJ9DGA86X9F786w5fTwd7bs4L2ILAp5pzA6SH5vUk_ilc9R6x3-k_Eeo54vigRF-Xz4zOnzR66k-6YaQFeHQGTreldMsH6fOJaSlpO559YHzgo6X33kHTZBsFCV6K2o-6i_6-Z363gwzo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1033833062</pqid></control><display><type>article</type><title>Suspected clozapine poisoning in the UK/Eire, 1992–2003</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Flanagan, R.J. ; Spencer, E.P. ; Morgan, P.E. ; Barnes, T.R.E. ; Dunk, L.</creator><creatorcontrib>Flanagan, R.J. ; Spencer, E.P. ; Morgan, P.E. ; Barnes, T.R.E. ; Dunk, L.</creatorcontrib><description>Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and
N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome.
Samples were referred from clinicians, pathologists/coroners, or via the
Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports.
There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4)
mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70)
mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7,
n
=
43) and 1.4 (0–6.0,
n
=
39)
mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6,
n
=
38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30,
n
=
21) days].
Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information.</description><identifier>ISSN: 0379-0738</identifier><identifier>EISSN: 1872-6283</identifier><identifier>DOI: 10.1016/j.forsciint.2004.10.024</identifier><identifier>PMID: 16226146</identifier><identifier>CODEN: FSINDR</identifier><language>eng</language><publisher>Kidlington: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Analysis ; Antipsychotic Agents - blood ; Antipsychotic Agents - poisoning ; Biological and medical sciences ; Clozapine ; Clozapine - analogs & derivatives ; Clozapine - blood ; Clozapine - poisoning ; Drug dosages ; Drug Overdose ; Drug therapy ; Fatal poisoning: clozapine ; Fatal poisoning: interpretation of results ; Female ; Forensic Medicine ; Forensic sciences ; Forensic toxicology ; General aspects ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Leukocyte Count ; Male ; Medical sciences ; Middle Aged ; Plasma ; Plasma:whole blood distribution: clozapine ; Poisoning ; Poisoning - diagnosis ; Post-mortem redistribution: clozapine ; Postmortem Changes ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Substance abuse treatment ; Suicide ; Toxicity ; Treatment Refusal ; United Kingdom</subject><ispartof>Forensic science international, 2005-12, Vol.155 (2), p.91-99</ispartof><rights>2004 Elsevier Ireland Ltd</rights><rights>2005 INIST-CNRS</rights><rights>COPYRIGHT 2005 The Lancet Publishing Group, a division of Elsevier Science Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</citedby><cites>FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0379073804007455$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17217522$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16226146$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Flanagan, R.J.</creatorcontrib><creatorcontrib>Spencer, E.P.</creatorcontrib><creatorcontrib>Morgan, P.E.</creatorcontrib><creatorcontrib>Barnes, T.R.E.</creatorcontrib><creatorcontrib>Dunk, L.</creatorcontrib><title>Suspected clozapine poisoning in the UK/Eire, 1992–2003</title><title>Forensic science international</title><addtitle>Forensic Sci Int</addtitle><description>Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and
N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome.
Samples were referred from clinicians, pathologists/coroners, or via the
Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports.
There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4)
mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70)
mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7,
n
=
43) and 1.4 (0–6.0,
n
=
39)
mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6,
n
=
38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30,
n
=
21) days].
Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information.</description><subject>Adult</subject><subject>Aged</subject><subject>Analysis</subject><subject>Antipsychotic Agents - blood</subject><subject>Antipsychotic Agents - poisoning</subject><subject>Biological and medical sciences</subject><subject>Clozapine</subject><subject>Clozapine - analogs & derivatives</subject><subject>Clozapine - blood</subject><subject>Clozapine - poisoning</subject><subject>Drug dosages</subject><subject>Drug Overdose</subject><subject>Drug therapy</subject><subject>Fatal poisoning: clozapine</subject><subject>Fatal poisoning: interpretation of results</subject><subject>Female</subject><subject>Forensic Medicine</subject><subject>Forensic sciences</subject><subject>Forensic toxicology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Leukocyte Count</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Plasma</subject><subject>Plasma:whole blood distribution: clozapine</subject><subject>Poisoning</subject><subject>Poisoning - diagnosis</subject><subject>Post-mortem redistribution: clozapine</subject><subject>Postmortem Changes</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Substance abuse treatment</subject><subject>Suicide</subject><subject>Toxicity</subject><subject>Treatment Refusal</subject><subject>United Kingdom</subject><issn>0379-0738</issn><issn>1872-6283</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkc2KFDEUhYMoTtv6ClogurJ68lNJJctmGH9wwIXOOqRTN22a6qRMqgRdzTvMG_okpujGRmmQLC7cfOfekxyEXhC8IpiIy93KxZSt92FcUYyb0l1h2jxACyJbWgsq2UO0wKxVNW6ZvEBPct5hjDmn4jG6IIJSQRqxQOrzlAewI3SV7eNPM_gA1RB9jsGHbeVDNX6F6vbj5bVP8KYiStFfd_dlJXuKHjnTZ3h2rEt0-_b6y9X7-ubTuw9X65vacsHGmrkNoS3mG0OMa40wikveKFqqxc5ZbhtGpWoZ6awinFhpyKZ4xp0imKuOLdHrw9whxW8T5FHvfbbQ9yZAnLImLVFYclXAl_-AuzilULxpghmTjGFBT9TW9KB9cHFMxs4j9ZowKQXFhV6i-gy1hQDJ9DGA86X9F786w5fTwd7bs4L2ILAp5pzA6SH5vUk_ilc9R6x3-k_Eeo54vigRF-Xz4zOnzR66k-6YaQFeHQGTreldMsH6fOJaSlpO559YHzgo6X33kHTZBsFCV6K2o-6i_6-Z363gwzo</recordid><startdate>20051220</startdate><enddate>20051220</enddate><creator>Flanagan, R.J.</creator><creator>Spencer, E.P.</creator><creator>Morgan, P.E.</creator><creator>Barnes, T.R.E.</creator><creator>Dunk, L.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><general>The Lancet Publishing Group, a division of Elsevier Science Ltd</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ILT</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20051220</creationdate><title>Suspected clozapine poisoning in the UK/Eire, 1992–2003</title><author>Flanagan, R.J. ; Spencer, E.P. ; Morgan, P.E. ; Barnes, T.R.E. ; Dunk, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-3fb12705ba1af7a6a9585492a95c0ffc5c43289731dc9151c8a1b0730d91059d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Analysis</topic><topic>Antipsychotic Agents - blood</topic><topic>Antipsychotic Agents - poisoning</topic><topic>Biological and medical sciences</topic><topic>Clozapine</topic><topic>Clozapine - analogs & derivatives</topic><topic>Clozapine - blood</topic><topic>Clozapine - poisoning</topic><topic>Drug dosages</topic><topic>Drug Overdose</topic><topic>Drug therapy</topic><topic>Fatal poisoning: clozapine</topic><topic>Fatal poisoning: interpretation of results</topic><topic>Female</topic><topic>Forensic Medicine</topic><topic>Forensic sciences</topic><topic>Forensic toxicology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Leukocyte Count</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Plasma</topic><topic>Plasma:whole blood distribution: clozapine</topic><topic>Poisoning</topic><topic>Poisoning - diagnosis</topic><topic>Post-mortem redistribution: clozapine</topic><topic>Postmortem Changes</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Substance abuse treatment</topic><topic>Suicide</topic><topic>Toxicity</topic><topic>Treatment Refusal</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flanagan, R.J.</creatorcontrib><creatorcontrib>Spencer, E.P.</creatorcontrib><creatorcontrib>Morgan, P.E.</creatorcontrib><creatorcontrib>Barnes, T.R.E.</creatorcontrib><creatorcontrib>Dunk, L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale OneFile: LegalTrac</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Forensic science international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flanagan, R.J.</au><au>Spencer, E.P.</au><au>Morgan, P.E.</au><au>Barnes, T.R.E.</au><au>Dunk, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suspected clozapine poisoning in the UK/Eire, 1992–2003</atitle><jtitle>Forensic science international</jtitle><addtitle>Forensic Sci Int</addtitle><date>2005-12-20</date><risdate>2005</risdate><volume>155</volume><issue>2</issue><spage>91</spage><epage>99</epage><pages>91-99</pages><issn>0379-0738</issn><eissn>1872-6283</eissn><coden>FSINDR</coden><abstract>Toxicological analyses are often performed to investigate suspected poisoning, but the interpretation of results may not be straightforward. We studied suspected poisoning cases 1992–2003 where blood clozapine and
N-desmethylclozapine (norclozapine) were measured in order to assess the relationship of these parameters to outcome.
Samples were referred from clinicians, pathologists/coroners, or via the
Clozaril Patient Monitoring Service (CPMS, Novartis). Information was gathered from clinical, post-mortem, or coroners’ reports.
There were seven fatal [five male, two female; median (range) age 28 (24–41) year] and five non-fatal [four male, one female; median age 35 (26–41) year] clozapine overdoses. The median post-mortem blood clozapine and norclozapine concentrations were 8.2 (3.7–12) and 1.9 (1.4–2.4)
mg/L, respectively [median clozapine:norclozapine ratio 4.4 (2.9–5.1)]. The median plasma clozapine and norclozapine concentrations (first or only sample) were 3.9 (1.7–7.0) and 0.40 (0.30–0.70)
mg/L, respectively [median clozapine:norclozapine ratio 7.6 (5.3–18)] in the remainder. These overdoses were in patients who were poorly or non-adherent to clozapine, or who had taken tablets prescribed for someone else. In 54 further people who died whilst receiving clozapine [38 male, 16 female; median age 41 (22–70) year], the median post-mortem blood clozapine and norclozapine concentrations were 1.9 (0–7.7,
n
=
43) and 1.4 (0–6.0,
n
=
39)
mg/L, respectively [median clozapine:norclozapine ratio 1.5 (0.4–7.6,
n
=
38)]. The median post-mortem increase in blood clozapine and norclozapine as compared to the most recent ante-mortem measurement was 489 (98–5350)% and 371 (139–831)%, respectively [median sample time before death 14 (0–30,
n
=
21) days].
Clozapine poisoning cannot be diagnosed on the basis of blood clozapine and norclozapine concentrations alone. The analysis of ante-mortem blood specimens collected originally for white cell count monitoring and the blood clozapine:norclozapine ratio may provide additional interpretative information.</abstract><cop>Kidlington</cop><pub>Elsevier Ireland Ltd</pub><pmid>16226146</pmid><doi>10.1016/j.forsciint.2004.10.024</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0379-0738 |
ispartof | Forensic science international, 2005-12, Vol.155 (2), p.91-99 |
issn | 0379-0738 1872-6283 |
language | eng |
recordid | cdi_proquest_miscellaneous_17190859 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adult Aged Analysis Antipsychotic Agents - blood Antipsychotic Agents - poisoning Biological and medical sciences Clozapine Clozapine - analogs & derivatives Clozapine - blood Clozapine - poisoning Drug dosages Drug Overdose Drug therapy Fatal poisoning: clozapine Fatal poisoning: interpretation of results Female Forensic Medicine Forensic sciences Forensic toxicology General aspects Humans Investigative techniques, diagnostic techniques (general aspects) Leukocyte Count Male Medical sciences Middle Aged Plasma Plasma:whole blood distribution: clozapine Poisoning Poisoning - diagnosis Post-mortem redistribution: clozapine Postmortem Changes Public health. Hygiene Public health. Hygiene-occupational medicine Substance abuse treatment Suicide Toxicity Treatment Refusal United Kingdom |
title | Suspected clozapine poisoning in the UK/Eire, 1992–2003 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A48%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suspected%20clozapine%20poisoning%20in%20the%20UK/Eire,%201992%E2%80%932003&rft.jtitle=Forensic%20science%20international&rft.au=Flanagan,%20R.J.&rft.date=2005-12-20&rft.volume=155&rft.issue=2&rft.spage=91&rft.epage=99&rft.pages=91-99&rft.issn=0379-0738&rft.eissn=1872-6283&rft.coden=FSINDR&rft_id=info:doi/10.1016/j.forsciint.2004.10.024&rft_dat=%3Cgale_proqu%3EA138862010%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1033833062&rft_id=info:pmid/16226146&rft_galeid=A138862010&rft_els_id=S0379073804007455&rfr_iscdi=true |